North China Pharmaceutical Company Ltd. (600812.SS)

CNY 5.49

(-0.54%)

Market Cap (In CNY)

8.95 Billion

Revenue (In CNY)

10.12 Billion

Net Income (In CNY)

4.89 Million

Avg. Volume

10.66 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
3.83-6.22
PE
-
EPS
-
Beta Value
1.156
ISIN
CNE000000D16
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Xin Yan Liu
Employee Count
-
Website
https://www.ncpc.cn
Ipo Date
1994-01-14
Details
North China Pharmaceutical Company Ltd. operates as a chemical pharmaceutical company in China. It primarily offers anti-infective drugs, comprising APIs, and intermediates and their preparations; biotechnology drugs; cardiovascular and immunomodulators; vitamins health consumer products; and bio-agricultural and veterinary drugs. North China Pharmaceutical Company Ltd. was founded in 1953 and is based in Shijiazhuang, China.